PureTech Health (PRTC) Invested Capital (2019 - 2025)

PureTech Health (PRTC) has 7 years of Invested Capital data on file, last reported at $312.1 million in Q4 2025.

• Invested Capital for Q4 2025 came in at $312.1 million, down 24.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $312.1 million (down 24.75% YoY), and the FY2025 annual result was $312.1 million, down 24.75% from the prior year.
• Invested Capital declined to $312.1 million in Q4 2025 per PRTC's latest filing, from $376.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $645.3 million in Q4 2022 and troughed at $312.1 million in Q4 2025.
• A 5-year average of $448.1 million and a median of $414.7 million in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2023 and 2025: Invested Capital declined 28.09% in 2023, then advanced 19.03% in 2025.
• A 5-year view of Invested Capital shows it stood at $608.6 million in 2021, then advanced by 6.03% to $645.3 million in 2022, then slipped by 28.09% to $464.1 million in 2023, then slipped by 10.64% to $414.7 million in 2024, then dropped by 24.75% to $312.1 million in 2025.
• Business Quant data shows PRTC's Invested Capital at $312.1 million in Q4 2025, $376.0 million in Q2 2025, and $414.7 million in Q4 2024.